IPP Bureau
MedGenome to expand integrated diagnostics access across Mumbai suburbs
By IPP Bureau - May 19, 2026
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
NunaBio secures £6.5 million to scale DNA manufacturing platform
By IPP Bureau - May 19, 2026
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children
By IPP Bureau - May 19, 2026
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
India’s top scientific minds discuss preparedness against emerging health threats
By IPP Bureau - May 19, 2026
Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges
HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin
By IPP Bureau - May 19, 2026
Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development
Annora Pharma expands partnership with AltiusHub to strengthen AI-driven serialization
By IPP Bureau - May 19, 2026
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
Zydus Wellness FY26 revenue climbs to Rs. 39.4 billion
By IPP Bureau - May 19, 2026
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
Strand Life launches advanced proteomics capabilities
By IPP Bureau - May 19, 2026
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity
By IPP Bureau - May 19, 2026
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Pfizer promotes Ashish Doshi as Director at IITM RP, Chennai
By IPP Bureau - May 19, 2026
Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
KIMS Hospitals posts strong revenue growth but profits slip sharply in FY26
By IPP Bureau - May 19, 2026
Profit after tax took a sharp hit, falling to Rs. 33 Cr in Q4 FY26, down from Rs. 106 Cr in Q4 FY25 and Rs. 52 Cr in Q3 FY26
Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge
By IPP Bureau - May 19, 2026
Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer
By IPP Bureau - May 19, 2026
The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients
Alivus Life Sciences posts steady FY26 growth as margins surge past guidance
By IPP Bureau - May 19, 2026
The company reported free cash flow of Rs. 2,590 Mn for FY26
